Our partners
Innovation in the heart of Paris.
The purpose of the MEARY Center is to catalyze the contribution of innovation in cell and gene therapies in order to promote and accelerate access to innovation in the healthcare system, to develop the national capacity to fulfill its mission of providing the best possible care to all patients, at a lower cost and with an industrial level of quality and safety.
This raison d'être is obviously developed with regard to the issues and challenges specific to the field of biotherapies, in particular the need to reduce costs and increase production capacity.
The MEARY Center is proud of these fruitful collaborations:
ASTRAVEUS
The start-up that is revolutionizing biotechnology and biomanufacturing with an integrated microfluidic production solution for cell and gene therapies.
MNEMO THERAPEUTICS
Mnemo Therapeutics is a biotechnology company that leverages epigenetics to create targeted immuno-oncology treatments accessible to a broad patient population.
SMARTIMMUNE
Smart Immune, a clinical stage biotechnology company, is developing an allogeneic cell therapy platform called ProTcell. This platform exploits the physiology of the thymus to rearm the immune system in record time.
MILTENYI BIOTEC
For more than 30 years, Miltenyi Biotec has played an important role in the design, development, manufacture, and integration of products that empower the advancement of biomedical research and enable cell and gene therapy.
BIOMERIEUX FRANCE
BioMérieux, a world leader in microbiology, has a proven track record in developing and marketing instruments and applications for clinical diagnostics and industrial quality control.
TREEFROG
TreeFrog wants to make cell therapies accessible to millions of patients. The startup has developed C-Stem™, a proprietary technology platform based on 3D stem cell culture in industrial bioreactors.
MADECELL
MadeCELL offers integrated management software, a unique solution, in response to the specific needs of major players in the field of cell, gene and tissue therapy.
EVERZOM
EVerZom is an exosome company developing a large-scale GMP-compliant manufacturing platform for exosome-based therapies based on a patented method.
AENITIS
Aenitis Technologies, which develops new medical devices for cell manipulation and sorting based on the use of acoustic energy.
I2S
i2S2 is at the forefront of image capture and processing, integrated in complete solutions, from the photon to the cloud. We capitalize on the rapid evolution of digital technologies and integrate them into global solutions.
MOLSID
Based on more than 15 years of R&D at the prestigious ENS University of Lyon, Molsid's patented SmartID technology is considered a breakthrough in the high-quality identification of enzymatic activity in living cells.